<p>Sensus Healthcare, Inc.（纳斯达克代码：SRTS - 获取免费报告）董事 Eric Sachetta 于 11 月 21 日星期五收购了 7,000 股 Sensus Healthcare 股票。该股票的平均购买价格为每股 3.93 美元，总价值为 27,510.00 美元。交易完成后，该董事直接持有公司 140,113 股股票，价值 550,644.09 美元。这代表其持股增加了 5.26%。该交易已在向 SEC 提交的文件中披露，您可以通过此超链接访问。</p>
<p>Eric Sachetta 最近还进行了以下交易：</p>
<ul>
<li>在 11 月 13 日星期四，Eric Sachetta 购买了 2,500 股 Sensus Healthcare 股票。该股票的平均价格为每股 4.50 美元，总交易额为 11,250.00 美元。</li>
</ul>
<p>获取 <strong>Sensus Healthcare</strong> 的提醒：</p>
<h2>Sensus Healthcare 股价上涨 1.9%</h2>
<p>在星期五的交易中，SRTS 股票上涨了 0.07 美元，达到了 4.00 美元。该公司的股票交易量为 49,595 股，而其平均交易量为 167,241 股。该公司的 50 日移动平均线为 3.45 美元，200 日移动平均线为 4.06 美元。Sensus Healthcare, Inc.的 52 周最低价为 3.03 美元，52 周最高价为 9.33 美元。该公司的市值为 6577 万美元，市盈率为-66.65，贝塔值为 1.38。</p>
<p>Sensus Healthcare（纳斯达克代码：SRTS - 获取免费报告）最近于 11 月 6 日星期四发布了其财报。该公司报告本季度每股收益（EPS）为-0.06 美元，超出分析师一致预期的-0.12 美元，超出幅度为 0.06 美元。Sensus Healthcare 的股本回报率为-1.58%，净利润率为-2.26%。该公司本季度的收入为 688 万美元，而分析师预期为 631 万美元。整体来看，研究分析师预测 Sensus Healthcare, Inc.在当前年度将发布 0.32 美元的每股收益。</p>
<h2>机构资金流入和流出</h2>
<p>几家对冲基金和其他机构投资者最近增加或减少了对该股票的持股。Vise Technologies Inc.在第二季度购买了 Sensus Healthcare 的新股份，价值约 52,000 美元。IFP Advisors Inc.在第一季度将其在 Sensus Healthcare 的持股增加了 37.2%。IFP Advisors Inc.现在拥有 18,800 股该公司的股票，价值 89,000 美元，此前在上个季度又购买了 5,100 股。Trexquant Investment LP 在第一季度购买了 Sensus Healthcare 的新头寸，价值 93,000 美元。American Century Companies Inc.在第一季度将其在 Sensus Healthcare 的持股增加了 12.7%。American Century Companies Inc.现在拥有 22,440 股该公司的股票，价值 106,000 美元，此前在上个季度又购买了 2,520 股。最后，Chapin Davis Inc.在第二季度将其在 Sensus Healthcare 的持股增加了 66.7%。Chapin Davis Inc.现在拥有 25,000 股该公司的股票，价值 118,000 美元，此前在上个季度又购买了 10,000 股。目前，25.30% 的股票由对冲基金和其他机构投资者持有。</p>
<h2>分析师设定新目标价</h2>
<p>一些股票分析师对该股票发表了看法。Lake Street Capital 将 Sensus Healthcare 的目标价从 13.00 美元下调至 6.00 美元，并在 8 月 8 日的研究报告中给予该公司 “买入” 评级。Wall Street Zen 在 11 月 8 日的报告中将 Sensus Healthcare 的评级从 “卖出” 上调至 “持有”。Zacks Research 在 10 月 22 日的研究报告中将 Sensus Healthcare 的评级从 “强烈卖出” 上调至 “持有”。HC Wainwright 在 8 月 12 日的研究报告中将 Sensus Healthcare 的目标价从 12.00 美元下调至 8.00 美元，并对该股票给予 “买入” 评级。最后，Weiss Ratings 在 10 月 8 日的报告中重申了对 Sensus Healthcare 的 “卖出（d）” 评级。三位分析师对该股票给予 “买入” 评级，一位给予 “持有” 评级，一位给予 “卖出” 评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “持有”，平均目标价为 8.00 美元。</p>
<p><strong>阅读我们最新的 SRTS 股票分析</strong></p>
<h2>关于 Sensus Healthcare</h2>
<p>（获取免费报告）</p>
<p>Sensus Healthcare, Inc.是一家医疗设备公司，向全球医疗服务提供商制造和销售放射治疗设备。该公司在其治疗设备组合中使用表面放射治疗，这是一种低能量 X 射线技术。它提供 SRT-100，这是一种光子 X 射线低能量表面放射治疗系统，为患者提供了一种替代手术的选择，用于治疗非黑色素瘤皮肤癌，包括基底细胞癌和鳞状细胞癌，以及其他皮肤病，如瘢痕疙瘩；以及 SRT-100 Vision，提供给用户一个针对表面放射治疗量身定制的治疗计划应用程序，集成了嵌入式高频超声成像模块、肿瘤体积分析、射束边缘规划和剂量参数。</p>
<h2>精选故事</h2>
<ul>
<li>我们更看好的五只股票，而非 Sensus Healthcare</li>
<li>技术指标如何帮助您找到被超卖的股票</li>
<li>Palo Alto Networks 股票刚刚回调——这是一个理想的买入区间吗？</li>
<li>三只国防股票将受益于军事支出的增加</li>
<li>Cloudflare 刚刚打破了互联网，但它仍然是一个炙手可热的买入</li>
<li>恒生指数是什么？</li>
<li>Anthropic 刚刚成为人工智能的热门项目——得到微软和 NVIDIA 的支持</li>
</ul>
<p><em>此即时新闻提醒是由叙述科学技术和 MarketBeat 的金融数据生成的，旨在为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>您现在应该投资 1,000 美元于 Sensus Healthcare 吗？</h2>
<p>在您考虑 Sensus Healthcare 之前，您需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Sensus Healthcare 并不在名单上。</p>
<p>虽然 Sensus Healthcare 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

Sensus医疗保健

<p>Sensus Healthcare 董事 Eric Sachetta 以每股 3.93 美元的价格购买了 7,000 股，总计 27,510 美元，增持幅度为 5.26%。该交易已在 SEC 备案中披露。Sensus Healthcare 的股票上涨了 1.9%，达到 4.00 美元，市值为 6577 万美元。分析师的评级意见不一，普遍维持 “持有” 评级，平均目标价为 8.00 美元。最近的财报超出预期，报告每股收益为（0.06 美元），而预测为（0.12 美元）。机构投资者已调整在公司的持股比例</p>

<p>Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report) Director Eric Sachetta acquired 7,000 shares of Sensus Healthcare stock in a transaction on Friday, November 21st. The stock was purchased at an average cost of $3.93 per share, with a total value of $27,510.00. Following the completion of the transaction, the director directly owned 140,113 shares in the company, valued at $550,644.09. This represents a 5.26% increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.</p>
<div class="lb-trans"><p>Sensus Healthcare, Inc.（纳斯达克代码：SRTS - 获取免费报告）董事 Eric Sachetta 于 11 月 21 日星期五收购了 7,000 股 Sensus Healthcare 股票。该股票的平均购买价格为每股 3.93 美元，总价值为 27,510.00 美元。交易完成后，该董事直接持有公司 140,113 股股票，价值 550,644.09 美元。这代表其持股增加了 5.26%。该交易已在向 SEC 提交的文件中披露，您可以通过此超链接访问。</p>
</div><p>Eric Sachetta also recently made the following trade(s):</p>
<div class="lb-trans"><p>Eric Sachetta 最近还进行了以下交易：</p>
</div><ul>
<li>On Thursday, November 13th, Eric Sachetta bought 2,500 shares of Sensus Healthcare stock. The stock was acquired at an average price of $4.50 per share, for a total transaction of $11,250.00.</li>
</ul>
<div class="lb-trans"><ul>
<li>在 11 月 13 日星期四，Eric Sachetta 购买了 2,500 股 Sensus Healthcare 股票。该股票的平均价格为每股 4.50 美元，总交易额为 11,250.00 美元。</li>
</ul>
</div><p>Get <strong>Sensus Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Sensus Healthcare</strong> 的提醒：</p>
</div><h2>Sensus Healthcare Trading Up 1.9%</h2>
<div class="lb-trans"><h2>Sensus Healthcare 股价上涨 1.9%</h2>
</div><p>Shares of SRTS stock traded up $0.07 during trading on Friday, hitting $4.00. The company's stock had a trading volume of 49,595 shares, compared to its average volume of 167,241. The business has a fifty day moving average of $3.45 and a 200-day moving average of $4.06. Sensus Healthcare, Inc. has a 52 week low of $3.03 and a 52 week high of $9.33. The company has a market cap of $65.77 million, a PE ratio of -66.65 and a beta of 1.38.</p>
<div class="lb-trans"><p>在星期五的交易中，SRTS 股票上涨了 0.07 美元，达到了 4.00 美元。该公司的股票交易量为 49,595 股，而其平均交易量为 167,241 股。该公司的 50 日移动平均线为 3.45 美元，200 日移动平均线为 4.06 美元。Sensus Healthcare, Inc.的 52 周最低价为 3.03 美元，52 周最高价为 9.33 美元。该公司的市值为 6577 万美元，市盈率为-66.65，贝塔值为 1.38。</p>
</div><p>Sensus Healthcare (NASDAQ:SRTS - Get Free Report) last released its earnings results on Thursday, November 6th. The company reported ($0.06) EPS for the quarter, topping analysts' consensus estimates of ($0.12) by $0.06. Sensus Healthcare had a negative return on equity of 1.58% and a negative net margin of 2.26%.The company had revenue of $6.88 million for the quarter, compared to analysts' expectations of $6.31 million. As a group, research analysts predict that Sensus Healthcare, Inc. will post 0.32 EPS for the current year.</p>
<div class="lb-trans"><p>Sensus Healthcare（纳斯达克代码：SRTS - 获取免费报告）最近于 11 月 6 日星期四发布了其财报。该公司报告本季度每股收益（EPS）为-0.06 美元，超出分析师一致预期的-0.12 美元，超出幅度为 0.06 美元。Sensus Healthcare 的股本回报率为-1.58%，净利润率为-2.26%。该公司本季度的收入为 688 万美元，而分析师预期为 631 万美元。整体来看，研究分析师预测 Sensus Healthcare, Inc.在当前年度将发布 0.32 美元的每股收益。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Vise Technologies Inc. purchased a new stake in Sensus Healthcare in the second quarter worth approximately $52,000. IFP Advisors Inc grew its holdings in shares of Sensus Healthcare by 37.2% during the 1st quarter. IFP Advisors Inc now owns 18,800 shares of the company's stock valued at $89,000 after purchasing an additional 5,100 shares during the last quarter. Trexquant Investment LP purchased a new position in Sensus Healthcare in the 1st quarter worth $93,000. American Century Companies Inc. lifted its stake in Sensus Healthcare by 12.7% in the first quarter. American Century Companies Inc. now owns 22,440 shares of the company's stock worth $106,000 after purchasing an additional 2,520 shares during the last quarter. Finally, Chapin Davis Inc. lifted its stake in Sensus Healthcare by 66.7% in the second quarter. Chapin Davis Inc. now owns 25,000 shares of the company's stock worth $118,000 after purchasing an additional 10,000 shares during the last quarter. 25.30% of the stock is currently owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>几家对冲基金和其他机构投资者最近增加或减少了对该股票的持股。Vise Technologies Inc.在第二季度购买了 Sensus Healthcare 的新股份，价值约 52,000 美元。IFP Advisors Inc.在第一季度将其在 Sensus Healthcare 的持股增加了 37.2%。IFP Advisors Inc.现在拥有 18,800 股该公司的股票，价值 89,000 美元，此前在上个季度又购买了 5,100 股。Trexquant Investment LP 在第一季度购买了 Sensus Healthcare 的新头寸，价值 93,000 美元。American Century Companies Inc.在第一季度将其在 Sensus Healthcare 的持股增加了 12.7%。American Century Companies Inc.现在拥有 22,440 股该公司的股票，价值 106,000 美元，此前在上个季度又购买了 2,520 股。最后，Chapin Davis Inc.在第二季度将其在 Sensus Healthcare 的持股增加了 66.7%。Chapin Davis Inc.现在拥有 25,000 股该公司的股票，价值 118,000 美元，此前在上个季度又购买了 10,000 股。目前，25.30% 的股票由对冲基金和其他机构投资者持有。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新目标价</h2>
</div><p>A number of equities analysts have weighed in on the stock. Lake Street Capital cut their target price on shares of Sensus Healthcare from $13.00 to $6.00 and set a &#34;buy&#34; rating for the company in a research report on Friday, August 8th. Wall Street Zen raised shares of Sensus Healthcare from a &#34;sell&#34; rating to a &#34;hold&#34; rating in a report on Saturday, November 8th. Zacks Research upgraded shares of Sensus Healthcare from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research note on Wednesday, October 22nd. HC Wainwright dropped their target price on Sensus Healthcare from $12.00 to $8.00 and set a &#34;buy&#34; rating on the stock in a research report on Tuesday, August 12th. Finally, Weiss Ratings reaffirmed a &#34;sell (d)&#34; rating on shares of Sensus Healthcare in a report on Wednesday, October 8th. Three analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of &#34;Hold&#34; and an average price target of $8.00.</p>
<div class="lb-trans"><p>一些股票分析师对该股票发表了看法。Lake Street Capital 将 Sensus Healthcare 的目标价从 13.00 美元下调至 6.00 美元，并在 8 月 8 日的研究报告中给予该公司 “买入” 评级。Wall Street Zen 在 11 月 8 日的报告中将 Sensus Healthcare 的评级从 “卖出” 上调至 “持有”。Zacks Research 在 10 月 22 日的研究报告中将 Sensus Healthcare 的评级从 “强烈卖出” 上调至 “持有”。HC Wainwright 在 8 月 12 日的研究报告中将 Sensus Healthcare 的目标价从 12.00 美元下调至 8.00 美元，并对该股票给予 “买入” 评级。最后，Weiss Ratings 在 10 月 8 日的报告中重申了对 Sensus Healthcare 的 “卖出（d）” 评级。三位分析师对该股票给予 “买入” 评级，一位给予 “持有” 评级，一位给予 “卖出” 评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “持有”，平均目标价为 8.00 美元。</p>
</div><p><strong>Read Our Latest Stock Analysis on SRTS</strong></p>
<div class="lb-trans"><p><strong>阅读我们最新的 SRTS 股票分析</strong></p>
</div><h2>About Sensus Healthcare</h2>
<div class="lb-trans"><h2>关于 Sensus Healthcare</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.</p>
<div class="lb-trans"><p>Sensus Healthcare, Inc.是一家医疗设备公司，向全球医疗服务提供商制造和销售放射治疗设备。该公司在其治疗设备组合中使用表面放射治疗，这是一种低能量 X 射线技术。它提供 SRT-100，这是一种光子 X 射线低能量表面放射治疗系统，为患者提供了一种替代手术的选择，用于治疗非黑色素瘤皮肤癌，包括基底细胞癌和鳞状细胞癌，以及其他皮肤病，如瘢痕疙瘩；以及 SRT-100 Vision，提供给用户一个针对表面放射治疗量身定制的治疗计划应用程序，集成了嵌入式高频超声成像模块、肿瘤体积分析、射束边缘规划和剂量参数。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Sensus Healthcare</li>
<li>How Technical Indicators Can Help You Find Oversold Stocks</li>
<li>Palo Alto Networks Stock Just Pulled Back—Is This a Prime Buy Zone?</li>
<li>3 Defense Stocks Set to Benefit From Increased Military Spending</li>
<li>Cloudflare Just Broke the Internet, But It’s Still a Red-Hot Buy</li>
<li>What is the Hang Seng index?</li>
<li>Anthropic Just Became AI’s Hottest Ticket—Backed by Microsoft and NVIDIA</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，而非 Sensus Healthcare</li>
<li>技术指标如何帮助您找到被超卖的股票</li>
<li>Palo Alto Networks 股票刚刚回调——这是一个理想的买入区间吗？</li>
<li>三只国防股票将受益于军事支出的增加</li>
<li>Cloudflare 刚刚打破了互联网，但它仍然是一个炙手可热的买入</li>
<li>恒生指数是什么？</li>
<li>Anthropic 刚刚成为人工智能的热门项目——得到微软和 NVIDIA 的支持</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒是由叙述科学技术和 MarketBeat 的金融数据生成的，旨在为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Sensus Healthcare Right Now?</h2>
<div class="lb-trans"><h2>您现在应该投资 1,000 美元于 Sensus Healthcare 吗？</h2>
</div><p>Before you consider Sensus Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在您考虑 Sensus Healthcare 之前，您需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sensus Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Sensus Healthcare 并不在名单上。</p>
</div><p>While Sensus Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Sensus Healthcare 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

内幕交易：Sensus 医疗保健（NASDAQ:SRTS）的一位董事购买了 7,000 股股票